HRSA Refines Injury Compensation Program Forms
Published Date: 3/18/2026
Notice
Summary
HRSA is updating the forms and questions for the Countermeasures Injury Compensation Program to make things easier and clearer for people filing claims. This affects anyone who might get injured by certain medical countermeasures, like vaccines or treatments during emergencies. The public can comment on these changes until April 17, 2026, and no new costs are expected.
Analyzed Economic Effects
6 provisions identified: 3 benefits, 3 costs, 0 mixed.
You Must Meet Filing Deadlines
You can apply to CICP at any time, but your eligibility for compensation is subject to meeting applicable filing deadlines and other program requirements. If you miss required filing deadlines or requirements, you may not be eligible for benefits.
No New Evidence After Final Decision
CICP allows you to supplement your Request for Benefits package with additional medical records before the Program makes a final decision, but after CICP makes a final decision there are no opportunities to submit additional medical records or supporting documents.
What Benefits CICP May Pay
CICP may pay unreimbursed medical expenses and/or lost employment income to eligible injured countermeasure recipients or to an estate for expenses and lost income accrued before death. If the administration or use of a covered countermeasure directly caused death, certain survivors may be eligible for a death benefit but not for unreimbursed medical expenses or lost employment income; survivors or their representatives must submit documentation such as a marriage license to prove survivor status.
Estimated Time Burden to File Claims
HRSA estimates total annual respondent burden of 5,223 hours for this information collection. Estimated hours include: Request for Benefits form — 360 respondents × 11.00 hours = 3,960 hours; Authorization form — 360 respondents × 2.00 hours = 720 hours; Additional medical documentation — 324 respondents × 0.75 hours = 243 hours; Supporting benefits documentation — 30 respondents × 10.00 hours = 300 hours.
CICP Forms Simplified and Updated
HRSA revised the Countermeasures Injury Compensation Program (CICP) forms and streamlined questions and contact information to make it easier and clearer for people filing claims related to covered countermeasures (for example, vaccines or treatments during emergencies). These are requests for continued OMB approval under OMB No. 0915-0334 and are intended to improve the information collection process.
Agency Expects No New Monetary Costs
HRSA states that no new costs are expected as a result of these revisions to the CICP information collection. The submission is a request for continued OMB approval of the collection (OMB No. 0915-0334).
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16871, Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Rural Maternity and Obstetrics Management Strategies Program Data Collection, OMB No. 0915-0394-Revision
In compliance with the requirement for opportunity for public comment on proposed data collection projects of the Paperwork Reduction Act of 1995, HRSA announces plans to submit an Information Collection Request (ICR), described below, to the Office of Management and Budget (OMB). Prior to submitting the ICR to OMB, HRSA seeks comments from the public regarding the burden estimate, below, or any other aspect of the ICR.
2026-16396, National Newborn Screening Stakeholder Workgroup
HRSA provides funding to support a national center for newborn screening systems known as the National Center for Newborn Screening Systems Excellence (NBS Excel). In fiscal year 2026, supplemental funding is being provided to NBS Excel to establish a national newborn screening stakeholder workgroup. This workgroup will be a pathway for conditions to be considered and recommended for inclusion in the Recommended Uniform Screening Panel (RUSP) and to discuss national- level issues related to newborn screening. Membership will include representatives from a wide range of newborn screening experts and stakeholders. The award recipient will convene the workgroup and develop findings, reports, and recommendations for HRSA's review and consideration. HRSA will then make recommendations to the Secretary of Health and Human Services, who has final decision-making authority on updates to the RUSP.
2026-16227, Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Transforming Pediatrics for Early Childhood Program Performance Measures
In compliance with the Paperwork Reduction Act of 1995, HRSA submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public during the review and approval period. OMB may act on HRSA's ICR only after the 30-day comment period for this notice has closed.
2026-16054, Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Organ Procurement and Transplantation Network Board of Directors and Committee Member Applications and Forms
In compliance with the requirement for opportunity for public comment on proposed data collection projects of the Paperwork Reduction Act of 1995, HRSA announces plans to submit an Information Collection Request (ICR), described below, to the Office of Management and Budget (OMB). Prior to submitting the ICR to OMB, HRSA seeks comments from the public regarding the burden estimate, below, or any other aspect of the ICR.
2026-15596, Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; National Health Service Corps Scholar/Students to Service Travel Worksheet, OMB No. 0906-0087-Revision
In compliance with the Paperwork Reduction Act of 1995, HRSA submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public during the review and approval period. OMB may act on HRSA's ICR only after the 30-day comment period for this notice has closed.
2026-15633, Notice Regarding 340B Rebate Model Pilot Program
The U.S. Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA), Office of Pharmacy Affairs (OPA), which administers the 340B Drug Pricing Program (340B Program), is issuing this Notice to announce the availability of a revised 340B Rebate Model Pilot Program (Pilot). The Pilot provides a rebate mechanism through which qualifying drug manufacturers may effectuate the 340B ceiling price for certain drugs sold to covered entities. Consistent with HRSA's longstanding statutory authority, rebates will be used instead of upfront discounts. HRSA issued a Request for Information (RFI) \1\ to gather input from interested parties regarding the potential use of rebates to effectuate the ceiling price under the 340B Program, including the standards and procedures that should govern the approval of manufacturer rebate plans and the impacts on all stakeholders. After carefully considering all comments from interested parties and different policy alternatives, HRSA is announcing this Pilot, which will implement a rebate approach for a limited set of drugs, and which builds on established and successful rebate programs. ---------------------------------------------------------------------------
Previous / Next Documents
Previous: 2026-05273, Combined Notice of Filings #1
The Federal Energy Regulatory Commission got a bunch of new electric rate filings from big energy players like ISO New England, PJM Interconnection, and Southern California Edison. These filings include updates to service agreements and tariff changes that could affect how electricity is priced and managed starting as early as February 27, 2026. If you’re involved in energy or power markets, keep an eye out—comments on these changes are due by April 3, 2026, and some changes kick in this spring and summer.
Next: 2026-05275, Physicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in Abbreviated New Drug Applications; Guidance for Industry, Availability
The FDA just released new rules to help companies making generic skin creams and gels prove their products work the same as brand-name ones. If you submit these drug applications, you’ll need to show detailed info about your product’s makeup and structure to get approval. This update starts now and aims to speed up safe, affordable generics without extra costs.